| Tag | Content |
|---|
EnhancerAtlas ID | HS133-18045 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr2:216545220-216546870 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gata1 | MA0035.3 | chr2:216546475-216546486 | AGAGATAAGGA | - | 6.02 | | IRF1 | MA0050.2 | chr2:216545601-216545622 | GAGAGAAAAGTGAAACAAATA | - | 6.13 | | MITF | MA0620.2 | chr2:216546738-216546756 | GAGGGTCACATGACTTCA | + | 6.13 | | MITF | MA0620.2 | chr2:216546738-216546756 | GAGGGTCACATGACTTCA | - | 6.13 | | Stat6 | MA0520.1 | chr2:216546819-216546834 | CATTTCTTGAGAACT | + | 7.19 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_02680 | chr2:216545306-216547009 | Astrocytes | | SE_45570 | chr2:216544833-216547498 | Osteoblasts | | SE_55663 | chr2:216543789-216547470 | u87 | | SE_67699 | chr2:216543789-216547470 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I215680 | chr2 | 216545057 | 216547522 |
|
Enhancer Sequence | AGAATAAAAG TAGAGATGAA AGAAATGGAT GTTCCTAAAA GAAACAACAG ATACCTTTTA 60
AAATACACTT TCAGTATAAC TAAGTACCTT TTCAAGTTGG TTAAAAAATT CTAAAAGTAG 120
AGTAGTCAAG TCCTTAAGTA ACATGACGAT CCTATCTACA GTTTAAATAA ATGTTCAGTC 180
ATCCCAACAG GAACAAATCA TAAAGAAAAT GTAAAGAATA TATCAAATTG GCTAAATGCA 240
TTCTATATTC GTAGTGTACT CACTGAAGCA TTGTTCGTGG GTTTTTTTTT TCTGATTCTT 300
ACCAAGCCTA CATATTTCTT TTTAATTTTT TCTTTTTATG TTTCCCAAGT TTACAGTTCA 360
CATAAAATAC CCACTGAAGC AGAGAGAAAA GTGAAACAAA TATTTCACAG CTCTTTGGGG 420
ATTTGAATGG GTTTTTACAA TAAAACCTTG ATTACTCAAA GAGCACAGGA GTGCCTGAAA 480
CCTGATAGAA GGAACAGAGA GCAGGCAGTT CTAAAGGTGC CAAGAGAGAC TCAGAACCTT 540
GTGGAGTTGA TGCACTGGCC CTTCAACCCT GGAACCCAGG CCAAGCACCA AACCAGGAAG 600
GGTCCAAACA GCCCTGAACA TGGCTATCGT GGCCAAACAA ACCAAAAAAA AAAAAGTCAC 660
TTGGAAAAGA TGTGCAAGGT TGTGGTTTCC TGATAAATTA AGATGACACA GGCAGTACCA 720
CAGGGCTTCC TTCATTACAT TATTGTGAAA TCTGGACTCA AATAGAATGA GGCAAACCCA 780
CAAGTTAAAG TGTTTTTAAA GTGGCTCAAT AATCACTTTG AAAACAGAAC ACCCTTTCAG 840
TCAGCATGAC TGGAACTTTG ATCAACAAAT CCCCAAGAGC CACAACCCGT CTTTTGTGAA 900
CAAGTAGTAT CAAGGTGGGG GTGGGCTTGG AGTGCACTGG ATGCTTTTCT TCTTTCATCA 960
TGAAACCTGG TGGTTTTGTG TCATGTGATA TGTTTTTCAG AGATTCGGCA GGAAGCTTGC 1020
ACCGAGTGAA GGATTTATAA AGATTATAGG AGATAACACA AAGCTATTTT ATCTCTTTAA 1080
AAAAAATCAA AGGTATTAAA TTTTTTTCTA CTTCATTTTT GTTTCCTCAT TTAAAAATTA 1140
GCTGCCACAA ATATTATCCC CCATCTGGGC ACAAGGTCAG TTGGCATACA ATTTTCTTCT 1200
TAATTTTCAT TTTCTGGATT CCTTGATGAC CTGATTTTGT ACAAATTCAT GCTGCAGAGA 1260
TAAGGATTGA TTGGCTACAA ATCAAGGATC TCTGCAGAAT GGGAATGAGA GACAAAGGAA 1320
GAGGAAGAGG ACGGACACCA CAAACCATCT TATCTTTTCA AAATGTGATT GGTGCATTTT 1380
CAACATTGGC TTACCTTTCC TTATGCTGTC CATAAATTTT GTGCAGGTGT AAGCTCATCC 1440
TACACATGTC ATTTGGACCA GACCAAGGCT GCTGTCATGG AGGACCCACA CCACAGCTTG 1500
GGAACCATTC ATCTACCAGA GGGTCACATG ACTTCAAATG ACTCTTCTAG GGGCCACCTG 1560
CCATGATAGG GTACCAGCTC TTCCTCTGAA TTCCCAATCC ATTTCTTGAG AACTACTGTT 1620
TCTAATAAGG TACTGTTTCT AATACCTTTC 1650
|
